110 related articles for article (PubMed ID: 22447931)
1. Megakaryocytes regulate expression of Pyk2 isoforms and caspase-mediated cleavage of actin in osteoblasts.
Kacena MA; Eleniste PP; Cheng YH; Huang S; Shivanna M; Meijome TE; Mayo LD; Bruzzaniti A
J Biol Chem; 2012 May; 287(21):17257-17268. PubMed ID: 22447931
[TBL] [Abstract][Full Text] [Related]
2. Megakaryocytes Enhance Mesenchymal Stromal Cells Proliferation and Inhibit Differentiation.
Emmakah AM; Arman HE; Alvarez MB; Childress PJ; Bidwell JP; Goebel WS; Gabriel Chu TM; Kacena MA
J Cell Biochem; 2017 Jul; ():. PubMed ID: 28722829
[TBL] [Abstract][Full Text] [Related]
3. Osteomacs promote maintenance of murine hematopoiesis through megakaryocyte-induced upregulation of Embigin and CD166.
Mohamad SF; El Koussa R; Ghosh J; Blosser R; Gunawan A; Layer J; Zhang C; Karnik S; Davé U; Kacena MA; Srour EF
Stem Cell Reports; 2024 Apr; 19(4):486-500. PubMed ID: 38458190
[TBL] [Abstract][Full Text] [Related]
4. Craniofacial Bone Tissue Engineering: Current Approaches and Potential Therapy.
Aghali A
Cells; 2021 Nov; 10(11):. PubMed ID: 34831216
[TBL] [Abstract][Full Text] [Related]
5. Myeloproliferative disorders and their effects on bone homeostasis: the role of megakaryocytes.
Karagianni A; Ravid K
Blood; 2022 May; 139(21):3127-3137. PubMed ID: 34428274
[TBL] [Abstract][Full Text] [Related]
6. Neonatal Osteomacs and Bone Marrow Macrophages Differ in Phenotypic Marker Expression and Function.
Mohamad SF; Gunawan A; Blosser R; Childress P; Aguilar-Perez A; Ghosh J; Hong JM; Liu J; Kanagasabapathy D; Kacena MA; Srour EF; Bruzzaniti A
J Bone Miner Res; 2021 Aug; 36(8):1580-1593. PubMed ID: 33900648
[TBL] [Abstract][Full Text] [Related]
7. A Pyk2 inhibitor incorporated into a PEGDA-gelatin hydrogel promotes osteoblast activity and mineral deposition.
Posritong S; Flores Chavez R; Chu TG; Bruzzaniti A
Biomed Mater; 2019 Feb; 14(2):025015. PubMed ID: 30658347
[TBL] [Abstract][Full Text] [Related]
8. Enhancement of osteoblast activity on nanostructured NiTi/hydroxyapatite coatings on additive manufactured NiTi metal implants by nanosecond pulsed laser sintering.
Deng B; Bruzzaniti A; Cheng GJ
Int J Nanomedicine; 2018; 13():8217-8230. PubMed ID: 30555235
[TBL] [Abstract][Full Text] [Related]
9. Megakaryocyte and Osteoblast Interactions Modulate Bone Mass and Hematopoiesis.
Alvarez MB; Xu L; Childress PJ; Maupin KA; Mohamad SF; Chitteti BR; Himes E; Olivos DJ; Cheng YH; Conway SJ; Srour EF; Kacena MA
Stem Cells Dev; 2018 May; 27(10):671-682. PubMed ID: 29631496
[TBL] [Abstract][Full Text] [Related]
10. Pyk2 deficiency potentiates osteoblast differentiation and mineralizing activity in response to estrogen or raloxifene.
Posritong S; Hong JM; Eleniste PP; McIntyre PW; Wu JL; Himes ER; Patel V; Kacena MA; Bruzzaniti A
Mol Cell Endocrinol; 2018 Oct; 474():35-47. PubMed ID: 29428397
[TBL] [Abstract][Full Text] [Related]
11. Osteomacs interact with megakaryocytes and osteoblasts to regulate murine hematopoietic stem cell function.
Mohamad SF; Xu L; Ghosh J; Childress PJ; Abeysekera I; Himes ER; Wu H; Alvarez MB; Davis KM; Aguilar-Perez A; Hong JM; Bruzzaniti A; Kacena MA; Srour EF
Blood Adv; 2017 Dec; 1(26):2520-2528. PubMed ID: 29296903
[TBL] [Abstract][Full Text] [Related]
12. Lnk Deficiency Leads to TPO-Mediated Osteoclastogenesis and Increased Bone Mass Phenotype.
Olivos DJ; Alvarez M; Cheng YH; Hooker RA; Ciovacco WA; Bethel M; McGough H; Yim C; Chitteti BR; Eleniste PP; Horowitz MC; Srour EF; Bruzzaniti A; Fuchs RK; Kacena MA
J Cell Biochem; 2017 Aug; 118(8):2231-2240. PubMed ID: 28067429
[TBL] [Abstract][Full Text] [Related]
13. Pyk2 and Megakaryocytes Regulate Osteoblast Differentiation and Migration Via Distinct and Overlapping Mechanisms.
Eleniste PP; Patel V; Posritong S; Zero O; Largura H; Cheng YH; Himes ER; Hamilton M; Ekwealor JTB; Kacena MA; Bruzzaniti A
J Cell Biochem; 2016 Jun; 117(6):1396-406. PubMed ID: 26552846
[TBL] [Abstract][Full Text] [Related]
14. C-Mpl Is Expressed on Osteoblasts and Osteoclasts and Is Important in Regulating Skeletal Homeostasis.
Meijome TE; Ekwealor JTB; Hooker RA; Cheng YH; Ciovacco WA; Balamohan SM; Srinivasan TL; Chitteti BR; Eleniste PP; Horowitz MC; Srour EF; Bruzzaniti A; Fuchs RK; Kacena MA
J Cell Biochem; 2016 Apr; 117(4):959-69. PubMed ID: 26375403
[TBL] [Abstract][Full Text] [Related]
15. Activated leukocyte cell adhesion molecule (ALCAM or CD166) modulates bone phenotype and hematopoiesis.
Hooker RA; Chitteti BR; Egan PH; Cheng YH; Himes ER; Meijome T; Srour EF; Fuchs RK; Kacena MA
J Musculoskelet Neuronal Interact; 2015 Mar; 15(1):83-94. PubMed ID: 25730656
[TBL] [Abstract][Full Text] [Related]
16. A novel role for thrombopoietin in regulating osteoclast development in humans and mice.
Bethel M; Barnes CL; Taylor AF; Cheng YH; Chitteti BR; Horowitz MC; Bruzzaniti A; Srour EF; Kacena MA
J Cell Physiol; 2015 Sep; 230(9):2142-51. PubMed ID: 25656774
[TBL] [Abstract][Full Text] [Related]
17. Signaling pathways involved in megakaryocyte-mediated proliferation of osteoblast lineage cells.
Cheng YH; Streicher DA; Waning DL; Chitteti BR; Gerard-O'Riley R; Horowitz MC; Bidwell JP; Pavalko FM; Srour EF; Mayo LD; Kacena MA
J Cell Physiol; 2015 Mar; 230(3):578-86. PubMed ID: 25160801
[TBL] [Abstract][Full Text] [Related]
18. The Rho-GEF Kalirin regulates bone mass and the function of osteoblasts and osteoclasts.
Huang S; Eleniste PP; Wayakanon K; Mandela P; Eipper BA; Mains RE; Allen MR; Bruzzaniti A
Bone; 2014 Mar; 60():235-45. PubMed ID: 24380811
[TBL] [Abstract][Full Text] [Related]
19. Pyk2 regulates megakaryocyte-induced increases in osteoblast number and bone formation.
Cheng YH; Hooker RA; Nguyen K; Gerard-O'Riley R; Waning DL; Chitteti BR; Meijome TE; Chua HL; Plett AP; Orschell CM; Srour EF; Mayo LD; Pavalko FM; Bruzzaniti A; Kacena MA
J Bone Miner Res; 2013 Jun; 28(6):1434-45. PubMed ID: 23362087
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
